DualityBio映恩生物是一家临床阶段的创新生物药公司,专注于为癌症和自身免疫性疾病患者研发新一代ADC治疗药物。映恩生物已成功构建了多个具有全球知识产权的新一代抗体药物偶联物(ADC)技术平台。基于对疾病生物学机制的深入研究和探索,映恩生物已有四个国际多中心(MRCT)临床阶段项目,并拥有十多项处于临床前阶段的创新项目。此外,映恩生物正在继续研发其新型蛋白质工程和ADC技术,以开发下一代“超级ADC”分子,包括不同有效载荷类别、双特异性ADC和双有效载荷ADC。
如需了解更多信息, 请参阅。
What does 映恩生物科技(上海)有限公司 require? Who is 映恩生物科技(上海)有限公司 hiring? recruitment: 电子/电器/通信技术类占比最多占41.9%,其次是计算机/网络/技术类占36.3%. What education can get in at ? 本科占比最多占43.5%,其次是硕士占39.5%. High education required at ? 硕士占39.5%,博士占6.5%. Work experience required at ? 不限占比最多占50%,其次是5-10年占25%. Where are the job locations at ? 上海占比最多占72.6%,其次是北京占12.9%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows